Skip to content
Screener

PP&E (Net) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$10.76B+11.6%
Labcorp Holdings logo
Labcorp HoldingsLH
$3.1B-1.1%
IQVIA logo
IQVIAIQV
$547M+2.1%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$2.15M-28.9%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$123.71M
NeoGenomics logo
NeoGenomicsNEO
$80.94M-5.3%

Segments

By geography

See full
Total Europe$29.82M+14.6%
Asia-Pacific$14.91M+2.5%
Europe, Other$6.82M-8.5%
Other$2.43M+2.9%

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Operating income$146.8M+16.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%
Free cash flow$138.1M-3.0%

Valuation

See full
Market cap$16.41B+35.7%
Enterprise value$16.05B+31.6%
P/E33.4×+4.5×
P/S5.9×+0.5×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025
(Amounts in thousands, except share amounts)As of / June 30,2026As of / December 31,2025
Accounts receivable and unbilled, net (includes $2.9 million and $3.5 million with related parties at June 30, 2026 and December 31, 2025, respectively)441,797402,078
Prepaid expenses and other current assets105,80090,497
Total current assets1,050,285989,624
Property and equipment, net157,114131,055
Operating lease right-of-use assets125,849117,815
Goodwill662,396662,396
Intangible assets, net33,11033,420
Deferred income taxes3,23119,223

Item 1. Financial Statements (unaudited)

FAQ

What is Medpace Holdings, Inc.'s PP&E (net)?
Medpace Holdings, Inc. (MEDP) reported PP&E (net) of $157.11M in Q2 2026.
How has Medpace Holdings, Inc.'s PP&E (net) changed year-over-year?
Medpace Holdings, Inc.'s PP&E (net) increased by 16.0% year-over-year, from $135.48M to $157.11M.
What is the long-term trend for Medpace Holdings, Inc.'s PP&E (net)?
Over 5 years (2020 to 2025), Medpace Holdings, Inc.'s PP&E (net) has grown at a 9.0% compound annual growth rate (CAGR), from $85.02M to $131.06M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Medpace Holdings, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude